Guardian Connect

by Medtronic  · Based in Ireland → — A continuous glucose monitoring (CGM) system that provides real-time glucose level monitoring and alerts on mobile devices, with AI capabilities for predicting blood glucose changes.
Endocrinology Family Medicine Internal Medicine

Subscription-based or outright purchase
Regulatory Status Disclosed

Overview

The Medtronic Guardian Connect system is a continuous glucose monitoring (CGM) system designed to help individuals with diabetes, aged 14 to 75 years, proactively manage their glucose levels. It continuously measures glucose levels in the interstitial fluid under the skin every five minutes, transmitting this data via Bluetooth to a compatible smartphone app. The system is notable for its predictive algorithms and AI capabilities, which can alert users to potential high or low glucose events up to 60 minutes in advance. This allows individuals to take preventative action and can significantly improve time spent within the target glucose range. The Guardian Connect system also offers exclusive access to the Sugar.IQ™ smart diabetes assistant, an AI-powered app developed with IBM Watson Health, which analyzes how an individual’s glucose levels respond to various factors like food intake, insulin dosages, and daily routines, providing personalized insights.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Real-time glucose monitoring on smartphone
  • Predictive alerts for high and low glucose events (up to 60 minutes in advance)
  • Sugar.IQu2122 smart diabetes assistant (AI-powered insights)
  • Customizable alerts and volume adjustments
  • Data sharing with care partners and healthcare professionals via CareLinku2122 Connect
  • Tracks daily activities (exercise, insulin, meals) to understand glucose impact
  • 7-day sensor wear
  • Water-resistant sensor
  • High accuracy (9% MARD for arm, 10.5% MARD for abdomen)
  • Compatible with iOS and Android devices

Use Cases

  • Continuous glucose monitoring for individuals with Type 1 and Type 2 diabetes (ages 14-75)
  • Proactive management of blood glucose levels for people using multiple daily insulin injections (MDI)
  • Preventing hypoglycemic and hyperglycemic events through predictive alerts
  • Personalized diabetes management insights through AI analysis of glucose data
  • Remote monitoring by care partners and healthcare professionals
  • Understanding the impact of diet, exercise, and medication on glucose levels

What Physicians Need to Know

Key Capabilities
Real-time continuous glucose monitoring (CGM) with readings every five minutes. Customizable predictive alerts for high and low glucose events up to 60 minutes in advance. Displays glucose levels, trends, and rate of change on a smartphone app. Integrates with the Sugar.IQu2122 diabetes assistant app (iOS only) for personalized insights based on food, exercise, and insulin. Allows users to track daily activities like exercise, insulin, and meals. Enables sharing of glucose data with care partners and healthcare professionals via the CareLinku2122 system.
Clinical Utility
Aids in proactive diabetes management by providing predictive alerts to help avoid high and low glucose events. Helps patients using multiple daily injections (MDI) to manage their diabetes more effectively. Clinical studies have shown it accurately alerts patients of hypoglycemic events (98.5% detection rate). Real-world data indicates that using Guardian Connect with the Sugar.IQ app can increase Time in Range (TIR) by 4.1%, representing about one extra hour per day. Predictive alerts have been shown to reduce low sensor glucose excursions by almost twofold and high sensor glucose excursions by fourfold. The system is intended to complement, not replace, information from standard blood glucose monitoring devices.
Integration Options
Connects to the Guardian Connect app on compatible iOS and Android smartphones. Data automatically uploads to the CareLinku2122 Therapy Management System for healthcare providers. Care partners can receive real-time glucose data and text alerts through the CareLinku2122 Connect web app. Compatible with smartwatches for push notifications. The Sugar.IQu2122 diabetes assistant app (iOS only) integrates with Guardian Connect data.
Compliance Status
U.S. Food and Drug Administration (FDA) approved for people with diabetes aged 14 to 75 years. Health Canada approved. Requires a prescription.
Pricing Model
Available through subscription plans, which may include the transmitter kit and monthly sensor shipments. Initial setup cost for the CGM device can be higher, with ongoing costs for sensors. Pricing can vary, with options for discounts on annual plans. Special B2B pricing may be available for medical professionals.
User Experience
Displays glucose data on a smartphone, offering a discreet way to monitor levels. Customizable alerts with adjustable volume and mute options. Easy sensor application process. Requires calibration with a blood glucose meter at least every 12 hours (Guardian Sensor 3). The app provides a user-friendly interface for calibration, logging events (exercise, meals, insulin), and viewing reports. Water-resistant for everyday activities.
Support Quality
Offers 24-hour technical support. Provides personalized support and training, including an onboarding program. Includes a 1-year manufacturer warranty.
Implementation Complexity
Requires a compatible mobile device (iOS or Android). Initial setup involves pairing the transmitter with the app and an internet connection. Training is provided for users, covering CGM basics, sensor insertion and calibration, and app features. The sensor is designed for up to 7 days of continuous wear. Requires regular calibration with fingerstick blood glucose measurements.
Evidence Base
Clinical studies demonstrate accuracy in detecting hypoglycemic events. Real-world data shows improved Time in Range and reduced glucose excursions when used with the Sugar.IQ app. A clinical study comparing Guardian Connect to Freestyle Libre found Guardian Connect to be superior in accuracy (MARD of 9.7% vs. 17.5%). Machine learning models trained on Guardian Connect data achieved 90% accuracy in predicting hypoglycemic events within a two-hour window. The Guardian Sensor 3 has a Mean Absolute Relative Difference (MARD) of 8.7% for arm placement and 10.5% for abdomen placement.
Physician Tip

Emphasize to patients that Guardian Connect is an adjunctive tool and does not replace fingerstick blood glucose measurements for therapy adjustments. Leverage the CareLinku2122 system for seamless access to patient data, enabling more productive office visits and informed treatment decisions. Encourage patients to utilize the predictive alerts and the Sugar.IQu2122 app (if applicable) to proactively manage glucose levels and improve Time in Range. Advise patients on the importance of consistent calibration for optimal sensor accuracy. Discuss compatible devices and proper app settings to ensure patients receive all necessary alerts.

The Guardian Connect system integrates with the Medtronic CareLinku2122 Therapy Management System for healthcare professional access to patient data and the Sugar.IQu2122 diabetes assistant app (iOS only) for personalized insights. It is a standalone CGM system and does not directly integrate with insulin pumps, though it can be used by individuals on multiple daily injections or those using insulin pumps separately. Data can be viewed on compatible iOS and Android smartphones, and push notifications can be sent to smartwatches.

Details

Category Endocrinology & Metabolic AI, Wearables & Remote Monitoring (RPM)
Pricing Subscription-based or outright purchase
DeploymentCloud-based (CareLink™ Personal)
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Endocrinology, Family Medicine, Internal Medicine

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Guardian Connect

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Guardian Connect.

View all on YouTube

Frequently Asked Questions

Guardian Connect uses predictive algorithms to anticipate hypoglycemic and hyperglycemic events up to 60 minutes in advance, providing real-time alerts to patients and caregivers. These algorithms are based on machine learning models trained on continuous glucose monitoring data, aiming to identify trends and patterns indicative of future glucose excursions. The system's AI primarily focuses on pattern recognition and predictive analytics to empower proactive diabetes management.
Guardian Connect adheres to strict data privacy and security protocols, including encryption of all transmitted and stored patient data, to ensure HIPAA compliance. Access to patient health information by AI algorithms is limited to de-identified and aggregated data for model training and improvement, with individual patient data only accessible to authorized users (patient and their designated healthcare providers) through secure, authenticated channels. Regular security audits and assessments are conducted to maintain the highest level of data protection.
While Guardian Connect's AI algorithms are robust, potential limitations or biases can exist, particularly in very rare or atypical physiological responses not extensively represented in training data. Medtronic continuously monitors the algorithm's performance across diverse patient populations and updates it to minimize bias and improve accuracy for all users. Physicians should consider individual patient factors and clinical judgment in conjunction with the device's predictions.
Guardian Connect offers integration capabilities with various EHR systems, allowing for the seamless flow of glucose data and AI-generated insights into a patient's medical record. Physicians can typically access and interpret these insights through a dedicated provider portal or directly within the EHR interface, where data is presented in an organized and actionable format, often including trend reports and alert summaries. Specific integration workflows may vary depending on the EHR system in use.
Several alternatives to Guardian Connect exist in the continuous glucose monitoring market with varying AI capabilities, such as the Dexcom G6 and Abbott FreeStyle Libre systems. Guardian Connect's pricing model typically involves the cost of the Guardian Sensor 3 and the Guardian Link 3 transmitter, often covered by insurance. Pricing can vary based on insurance plans and local distributors, and physicians should compare the overall cost and features with alternative systems to determine the best fit for their patients.
Guardian Connect, including its predictive AI features, has received necessary regulatory clearances, such as FDA approval in the United States, for its intended use. Medtronic conducts ongoing post-market surveillance and real-world evidence studies to continuously monitor the device's performance, safety, and the effectiveness of its AI algorithms. This ensures continued compliance with regulatory standards and informs future product enhancements.
Medtronic provides comprehensive training and support for both physicians and patients to ensure effective utilization of Guardian Connect's AI-driven features. This includes educational materials, online resources, and dedicated support teams to assist with device setup, data interpretation, and troubleshooting. For physicians, specific training on interpreting AI-generated alerts and trends is available to facilitate informed clinical decision-making.

Related Tools

EatLove
EatLove
Endocrinology & Metabolic AI
EatLove is an AI-powered digital health platform that provides personalized nutrition plans and meal recommendations for patients, designed to be used by healthcare professionals.
CGM Analytics (CompuGroup Medical)
CompuGroup Medical
Endocrinology & Metabolic AI
CGM Analytics is a healthcare data aggregation and analytics software solution for physician practices to analyze patient data and manage populations.
AI Health Clinic
AI Health Clinic
Clinical Decision Support & Reference
AI Health Clinic provides AI that amplifies clinicians by analyzing CGM, body composition, labs, and wearables to create a metabolic index, triage patients, and draft care plans for physician approval.
90Health
90Health
Endocrinology & Metabolic AI
90Health offers a complete digital solution for managing chronic disease with AI-powered programs, cognitive behavioral lessons, data monitoring, compassionate coaching, and care coordination.
Twin Health
Twin Health
Endocrinology & Metabolic AI
Twin Health uses AI Digital Twin technology to provide precision care for metabolic conditions, offering real-time monitoring, AI-driven insights, and personalized plans to support diabetes remission and medication reduction.
Tidepool Loop
Tidepool
Endocrinology & Metabolic AI

See all Endocrinology & Metabolic AI tools →

More from Medtronic

Aurora EV ICD (DVEA3E4)
Medtronic
Cardiology AI
The Aurora EV-ICD™ system is a first-of-its-kind extravascular defibrillator that treats sudden cardiac arrest and abnormal heart rhythms with defibrillation and anti-tachycardia pacing (ATP) in a single device. Its lead is placed outside the heart and veins, under the breastbone, to potentially reduce complications associated with transvenous leads.
LINQ II Insertable Cardiac Monitor
Medtronic
Cardiology AI
The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias.
Reveal LINQ
Medtronic
Cardiology AI
Medtronic Reveal LINQ is a tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythm™ AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-08-05 | First Added: 2026-08-05
AI Tool Finder
AI-powered search. Results may not be comprehensive.